Patents

US 12404239 B2: Modulators of BCL6 as ligand directed degraders

Granted
2025-09-02
Filed
2023-04-27 application 18140129
Type
Utility · 10 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are compounds and compositions thereof for modulating BCL6. In some embodiments, the compounds and compositions are provided for treatment of cancer or an autoimmune disease.

Source: PVGPATDIS, file of 2026-04-10 (ipg250902.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Celgene Corporation 413 patentsUS company or organizationPrinceton, NJPVGPATDIS, file of 2026-04-10
BRISTOL-MYERS SQUIBB COMPANY 1,812 patentsUS company or organizationPrinceton, NJBRISTOL MYERS SQUIBB CO SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Dehua HuangSan Diego, CA26PVGPATDIS, file of 2026-04-10
Matthew D. AlexanderSan Diego, CA33PVGPATDIS, file of 2026-04-10
Brandon W. WhitefieldSan Diego, CA20PVGPATDIS, file of 2026-04-10
Hunter Paul ShunatonaSan Diego, CA27PVGPATDIS, file of 2026-04-10
Dharmpal S. DoddEscondido, CA40PVGPATDIS, file of 2026-04-10
Deborah MortensenSan Diego, CA21PVGPATDIS, file of 2026-04-10
Giulianna MiseoSan Diego, CA1PVGPATDIS, file of 2026-04-10
Natalie Holmberg-DouglasSan Diego, CA1PVGPATDIS, file of 2026-04-10
Jayce RhodesSan Diego, CA1PVGPATDIS, file of 2026-04-10
Jennifer GriffinSan Diego, CA2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D209/34PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-05-27Assignment
Nunc pro tunc assignment
CELGENE CORPORATION signed 2026-05-06BRISTOL-MYERS SQUIBB COMPANY PRINCETON, NJ74769/252PASDL, file of 2026-10-15
2024-07-05Assignment
Assignment of assignor's interest
MORTENSEN, DEBORAH SUE signed 2024-02-07
HUANG, DEHUA signed 2024-02-14
GRIFFIN, JENNIFER signed 2024-03-06
WHITEFIELD, BRANDON WADE signed 2024-03-06
ALEXANDER, MATTHEW DAVID signed 2024-06-27
CELGENE CORPORATION PRINCETON, NJ67915/668ECORSEXC, file of 2026-09-25
2024-07-05Assignment
Assignment of assignor's interest
DODD, DHARMPAL S. signed 2024-02-07
SHUNATONA, HUNTER PAUL signed 2024-02-07
MISEO, GIULIANNA signed 2024-02-12
HOLMBERG-DOUGLAS, NATALIE signed 2024-02-16
RHODES, JAYCE signed 2024-03-11
BRISTOL-MYERS SQUIBB COMPANY PRINCETON, NJ67915/576ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.